iReact - Intelligent Multimodal Digital Ophthalmic Measuring Device with enabled AI Tele-Ophthalmology

这项英国/新加坡研发合作结合了专业医疗设备设计师、人为因素、软件/电子工程师、眼科专家临床医生的团队，开发了一种价格合理、专利、可靠且易于使用的设备，即iReact智能多模态数字眼科测量设备，支持人工智能远程眼科。眼科检查是现代医疗保健中无处不在的一部分。通过一系列详细描述的检查，可以实现视力的保存和眼部及其他疾病的早期发现。假阳性转诊、现有的候诊名单、疫情加剧和需要长期眼科护理的人口日益增多，但却没有相应数量的眼科医生和临床资源来满足这一需求——能力面临压力——从而增加了患者出现不良后果的风险。这就需要一种创新的眼科技术，以减少需求，并在最需要的患者中快速识别和监测眼病。iReact技术将眼部成像评估和测试结合起来，为英国、新加坡和全球市场的数百万患者提供服务。除了明显的保健和减少残疾福利外，这项技术还将大大节省保健和社会保健服务的费用。市场和投资回报是全球性的。目前只能在专业眼科诊所进行测量，最终将通过高街眼镜店和初级保健中心使用复杂但操作简单的设备进行测量。大规模使用iReact减少眼科门诊预约，通过减少不必要的转诊和实现社区/初级保健眼科检查，每年将为NHS节省数百万英镑。眼科是NHS最繁忙的专业之一，每年提供超过900万次门诊预约，每年花费超过10亿英镑。随着人口老龄化，青光眼等与年龄有关的视力损害疾病的患病率和治疗费用都急剧增加。然而，如果及早诊断并进行仔细监测，很大一部分视力丧失和失明是可以预防的。如果不加以控制，视力丧失和失明会给个人和国家造成相当大的健康负担。据估计，成年人的视力损失每年给英国经济造成280亿英镑的损失。NHS长期计划认识到这些需求，并支持社区和初级保健对眼保健服务的需求，这可以帮助减少不必要的转诊到专科眼科诊所。通过综合眼保健途径进行大规模提供，重点是早期发现、有效转诊和及时获得和治疗，有助于减少不必要的视力损失。

This UK/Singapore R&D collaboration combines a team of specialist Medical Device Designers, Human-factors, Software/Electronic Engineers, Eye Specialist clinicians to develop an affordable, patented, reliable, and easy-to-use device, the iReact Intelligent Multimodal Digital Ophthalmic Measuring Device with enabled AI Tele-Ophthalmology.Eye tests are a ubiquitous part of modern healthcare. Preservation of sight and the early detection of both eye and other diseases are accomplished by a range of well described tests.False-positive referrals, existing waiting-lists, Covid-exacerbation and ageing populations requiring long-term eye-care is growing without the commensurate number of Ophthalmologists and Clinical resources to meet this demand-pressure on capacity - increasing risk of adverse-outcomes-for-patients.This creates the need for an innovative ophthalmic-technology to reduce-demand and rapidly identify and monitor eye-disease in patients who need it most.iReact technology combines eye imaging assessment and testing bringing it to millions of patients in the UK, Singapore and Global market. Apart from the obvious health and reduction in disability benefits this technology will also bring significant cost savings to health and social care services. The market, and return on investments, is worldwide.Measurements currently only made in specialist eye clinics, will be eventually be available through high street opticians and Primary Care using a sophisticated but simple to operate device.Reducing eye-care outpatient appointments with the iReact, deployed at scale, will save the NHS £millions/year by reducing unnecessary referrals and enabling community/primary care-eye-testing.Ophthalmology is one of the busiest specialties in the NHS, providing over 9 million outpatient appointments per year costing over £1Billion/year.Age-related sight-impairing diseases such as Glaucoma have dramatically increased in prevalence and in treatment costs as the population ages. However, a significant proportion of sight-loss and blindness is preventable if diagnosed early and with careful monitoring. Unchecked, sight-loss and blindness cause a considerable health burden on individuals and the state. Its estimated sight-loss in adults costs the UK economy £28 billion a year.The NHS Long Term plan recognises these demands and supports the need for eye-care services at Community and Primary care that can help reduce unnecessary referrals to specialist eye clinics. Provided at scale, linked via Integrated-Eye-Care-Pathways focusing on early detection, effective referrals and prompt access and treatment helping to reduce unnecessary sight-loss.